BOULDER — MBio Diagnostics Inc., a Boulder-based biotech company that does rapid on-site sample testing, has raised $620,000 in capital.
MBio is raising funds through a debt offering and option to acquire other securities, according to a Form D filed with the U.S. Securities and Exchange Commission on May 21. The date of first sale was in December last year. MBio did not respond to a request for more information.
During May and June we celebrate the fastest growing private companies in Northern Colorado and the Boulder Valley with BizWest Media’s Mercury 100 Awards.
Companies that may be looking for a spot on this coveted list may benefit from asking themselves a few questions while striving for or managing substantial growth within their business.
MBio is looking to provide rapid testing with technology that goes beyond the traditional paper test (such as what at-home pregnancy tests do today), according to the company’s website. The company has created its “lightdeck technology,” which uses fluorescence illumination and imaging for its tests.